- Comprar cripto
- Mercados
- Futuros
- Spot
- Copy trading
WE-Launch
Bloomberg: Arthur Hayes has recently made a significant investment in a human longevity extension company and has been receiving regular intravenous stem cell infusion therapy over the past year.
BlockBeats News, August 21st. According to Bloomberg, BitMEX co-founder Arthur Hayes is shifting his investment focus to the field of human life extension. He recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly flown to receive intravenous infusion treatments, stating that he "hopes to extend his life as healthily as possible." While the company's name was not disclosed due to ongoing rebranding, he emphasized: "This is a future trend - an increasing number of countries are relaxing regulations on stem cell usage."
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
WSJ: Investors are Wary of a New Round of the "Crypto Winter"
Aethir Releases 12-Month Future Roadmap to Accelerate Growth in Global Enterprise AI Computing Business
24-hour Spot Funding Inflow/Outflow List: ETH Net Outflow of $126 million, ZEC Net Outflow of $18.2 million
Bloomberg: Fed Never So Split on Long Rate Strategy
Key Transaction Data: US 10-Year Treasury Yield Rises to 4.086%
Atención al cliente：@weikecs
Cooperación empresarial：@weikecs
Trading cuantitativo y MM：[email protected]
Programa VIP：[email protected]
App